Nicholas Matthew Maounis
CIK 1492953 · last filed 2014-02-13
Nicholas Matthew Maounis is a corporate insider who has filed 13 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing shows the insider sold $36.5K of ACFN on Feb 13, 2014. Across all open-market trades the lifetime net is −$278.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions. 22 SEC filings were submitted jointly with Verition Fund Management LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TGALD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
GREENWICH, CT 06830
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACFN | 10%+ Owner | 79,288 | $16.10 | $1.28M | -$36.9K | 3 | 2014-02-13 |
| Rennova Health, Inc. (TGALD) Delisted | 10%+ Owner | 790,319 | — | — | -$241.4K | 7 | 2010-08-17 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-02-13 | ACFN | Sell (S) | −9,700 | -$36.5K | EDGAR |
| 2014-02-11 | ACFN | Sell (S) | −100 | -$377 | EDGAR |
| 2013-05-14 | ACFN | Buy (P) | — | $0 | EDGAR |
| 2013-03-06 | — | Buy (P) | +1,400 | $1.8K | |
| 2011-12-20 | — | E | — | $0 | |
| 2011-09-22 | — | Sell (S) | — | $0 | |
| 2010-08-17 | Rennova Health, Inc. (TGALD) Delisted | Sell (S) | −116,146 | -$55.6K | EDGAR |
| 2010-07-26 | Rennova Health, Inc. (TGALD) Delisted | Sell (S) | −55,090 | -$40.7K | EDGAR |
| 2010-07-01 | Rennova Health, Inc. (TGALD) Delisted | Sell (S) | −14,231 | -$10.6K | EDGAR |
| 2010-06-25 | Rennova Health, Inc. (TGALD) Delisted | Sell (S) | −61,578 | -$47.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.